Clinical Chemistry

Article	Citations
Persistently Positive Urine Amphetamines Confirmation Testing	146
Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?	106
Clinical Chemistry’s Invited Reviewers 2021	91
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology	81
Unexpected Persistently Increased Intraoperative Parathyroid Hormone Concentrations in a Patient with Primary Hyperparathyroidism	75
Correction to: Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests	67
Low Free T4 in a 13-Year-Old Girl with Short Stature and Blurry Vision	65
Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl	64
Prenatal Hemoglobinopathy Evaluation	63
Clinical Chemistry's Invited Reviewers 2024	61
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma	56
Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test	56
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer	54
Third-Generation Single-Molecule Sequencing for Preimplantation Genetic Testing of Aneuploidy and Segmental Imbalances	53
The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19	52
Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries	51
Comprehensive Analysis of PKD1 and PKD2 by Long-Read Sequencing in Autosomal Dominant Polycystic Kidney Disease	51
B-314 Utility of he4 in differential diagnosis of pleural effusions	48
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-19	47
A-194 Intravenous Fluid Contamination of Basic Metabolic Panels Is Underrecognized by Manual Workflows	47
A-125 Difference Between the Results of Vitros® Dry Biochemistry and Wet Biochemistry with Kinetic Method in Diagnosing the Comorbidity of Lung Adenocarcinoma and Aacroamylasemia: Case Report	47
B-048 Proposal of a new monitoring algorythm for patients with a HIV positive result with the Elecsys HIV DUO test	45
B-080 Analytical Performance of ESPLINE HTLV-I/II	44
A-390 Implementation of the New GEM Hemochron 100 Point-of-care Coagulation System for Heparin Monitoring During Cardiopulmonary Bypass Procedures	42
B-276 Preservation of Proteomic Inflammatory Biomarkers signal in a Saliva Multiomic Buffer at Room Temperature	40

B-102 The Impact of Protein / Protein Interactions on Serum Free Light Chain Assay Calibration	39
A-377 The Selection and Implementation of POC Illicit Drug Toxicology Testing in Hamad Medical Corporation - Doha, Qatar	39
B-255 Engineered Reverse Transcriptases and Taq DNA Polymerases Deliver Robust Yield in the Presence of Clinically Relevant Inhibitors	36
B-097 Storage Stability of HbA1c in Whole Blood Tubes at Room Temperature on the Abbott Alinity c Clinical Chemistry System	36
B-090 Evaluation of Clinical Serology Assays Through the Development of Linearity Materials for aHBs IgG, Rubella IgG, and Toxoplasma IgG	36
B-247 Rapid and Field-deployable Microchip-based Real-time PCR for Hepatitis B Virus DNA Detection	35
A-143 Comparative Evaluation of K2EDTA Performance in Multinational Vacutainers: A Case Study of “DBO” by Schraubg and “BD” by Becton, Dickinson	35
B-305 A Novel Dilute-n-shoot Method for Quantitating Isotonitazene and Desmetonitazene in Human Urine By LC/MS	35
A-059 Validation of self-collected capillary dried blood spot collection for clinical HbA1c testing	32
A-101 Is That Unexpected? Education on Handling Real World Complications with Tightly Controlled Analytes During Method Evaluation	32
B-208 Room Temperature Stable PCR Reagents Preparation Using Capillary-Mediated Vitrification Process	31
A-173 Evaluation of Artificial Intelligence (AI)-assisted Flow Cytometry Analysis for Plasma Cell Neoplasms	31
A-343 Novel In-Line Hemolysis Detection on a Blood Gas Analyzer for Capillary Samples	31
B-253 Using biomarkers in recurrent renal stone formers to detect silent stones	31
A-023 Performance Evaluation of the Atellica IM High-Sensitivity Troponin I Assay on the Atellica CI 1900 Analyzer	30
A-339 Utomated Flow of a Non-invasive Fetal Gender Determination Lab-developed Molecular Test	29
B-011 Analytical Validation of a New Vasoactive Intestinal Peptide Radioimmunoassay	29
B-092 Effect of the Increased Specificity in a Recombinant anti-tTG Assay on a Celiac Disease Diagnostic Algorithm	28
A-292 The Use of Third-Party Controls During Covid-19 Pandemic: An Alternative to the Lack of Other Respiratory Infections	28
B-067 Human IgE Monoclonal Antibodies as Unique Tools for Allergy Diagnostics	28
A-117 Performance Evaluation of five Sentinel Diagnostics’ Assays on Beckman Coulter DxC 500 AU Clinical Chemistry Analyzer	28
B-110 Validation of Digital and Automated anti-dsDNA IFA Interpretations Using the dIFine Automated Fluorescent Microscope System	28
A-142 Comparison of Alinity c Hemoglobin A1c Immunoassay with Premier Hb9210 Automated HPLC Assay: Very Few Patients May be Outside Reportable Range Using Alinity c.	28
Cardiac Troponin I or T for the Diagnosis of Myocardial Infarction and Prediction of Outcomes—Does It Matter?	27
Ceramide Risk Scores Can Bring Lipidomics to Clinical Medicine	27
A Comprehensive Review of Estradiol, Progesterone, Luteinizing Hormone, and Follicle-Stimulating Hormone in the Context of Laboratory Medicine to Support Women's Health	27
Evolutions in Clinical Chemistry	27
Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication	27
Lower Limits for Reporting High-Sensitivity Cardiac Troponin Assays and Impact of Analytical Performance on Patient Misclassification	27
We All Know Standardization Is Key, But How Do We Get There with Clinical Metagenomics?	25
Abatacept as a Mimic of Gamma Heavy Chain Disease	25
Establishing Pragmatic Analytical Performance Specifications for Blood Beta-Hydroxybutyrate Testing	25
A New Concept for Reference Change Values—Regression to the Population Mean	24
Enrichment of Microbial DNA in Plasma to Improve Pathogen Detection in Sepsis: A Pilot Study	24
Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory	24
A Large Number of Fresh Samples and a Wide Range of Total Prostate-Specific Antigen (tPSA) Concentrations Is Important to Detect Differences in PSA Methods	23
Assessing the Quality of Metagenomic Next-Generation Sequencing for Pathogen Detection in Lower Respiratory Infections	23
“Fireworks” in Fatty Urine	23
A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol	23
Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families	23
A “Total” Interference	22
Commentary on Multiple Copy Number Variants Detected by Noninvasive Prenatal Screening	22
A Paradigm Shift: Engagement of Clinical Chemistry and Laboratory Medicine Trainees by Innovative Teaching Methods	22
Low-Pass Whole Genome Sequencing of Cell-Free DNA from Cerebrospinal Fluid: A Focus on Pediatric Central Nervous System Tumors	21
A Comment about Analytical Performance Specifications for the Combined Measurement Uncertainty Budget in the Implementation of Metrological Traceability of Parathyroid Hormone	21
Reflecting on 70 Years of Clinical Chemistry	21
New American Society of Hematology Thrombophilia Guidelines Could Provoke Surge in Laboratory Testing	21
UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers	20
Commentary on A Patient with Coarse Facial Features and Molecular Odyssey: Lessons Learned and Best Practice	20
Long-Term Within- and Between-Subject Biological Variation Data of Hematological Parameters in Recreational Endurance Athletes	20

Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders	20
Sex-Specific Absolute Delta Thresholds for High-Sensitivity Cardiac Troponin T	19
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application o	19
Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment	19
Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles	19
B-214 Mutational Landscapes of Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Database-Driven Comprehensive Myeloid Panel Analysis of DNA Variants and Gene Fusions	19
Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases	19
B-213 Including Turner Syndrome Screening in Newborn Sequencing by Using NGS Read Counts to Infer Sex Chromosomes Copy Number: Leveraging Existing Data to Enhance Early Diagnosis	18
B-173 Cystine Analysis in Urine Sample Using the Laser Diode Thermal Desorption technique “LDTD”/Mass Spectrometry (Luxon)	18
B-015 Magnesium Fractionation using Ultrafiltration System	18
A-128 Analytical Performance Evaluation of Assays Used for Iron Studies on the Atellica® CI 1900 Analyzer	18
B-222 Receptor-donor CYP3A5 and CYP3A4 genotype testing in liver transplant patients and its influence in tacrolimus blood levels: a retrospective study	18
A-180 A Retrospective Review of Syphilis Serology Interpretation Accuracy	18
B-266 Therapeutic Drug Monitoring of Natalizumab and Anti-Natalizumab Antibodies	18
B-301 In-vivo Continuous Therapeutic Drug Monitoring With Electrochemical Aptamer-based Sensors	18
B-138 A Harmonization Program Leading to Improved Accuracy and Precision of Hemoglobin A1c (HbA1c) Testing: A Six-Year Multi-Site, Multi-Instrument Review and Comparison	18
B-182 Development and validation of an LC-MS/MS assay for simultaneous measurement of serum androstenedione and 17-hydroxyprogesterone in serum	18
B-071 Unraveling Histamine Intolerance: Exploring DAO Quantity, Elimination Ratios and Cofactor Influences	17
B-329 Comparison Between Trough and AUC Monitoring of MPA in Patients With and Without Organ Transplantation. Influence of the Co-administered Immunosuppressant	17
B-107 Advancing Parasitology Laboratory Quality and Processes Through Artificial Intelligence (AI) and Automation	17
B-147 Evaluation of Laboratory Database: Is there a Causal Relationship between COVID-19 and Type 1 Diabetes	17
A-002 Analytical Validation of the Zybio High Sensitivity Cardiac Troponin I CLIA Assay	17
B-010 Comparison of Manual Urine Dipstick and Microscopy With Automated UC-3500 and UF-4000 Sysmex UN Series Urinalysis; A Comparative Experimental Research Approach at an Urban Referral Hospital in G	17
B-242 Improved Patient Satisfaction With Novel Capillary Blood Collection Devices as an Alternative to Venipuncture for Applications in Clinical Proteomic Assays	17
B-378 Cell-free Plasma Preparation Workflow Solution	16
A-342 Precision Evaluation of the pH, PO2 and PCO2 tests in the i-STAT® G3+ Cartridge using the i-STAT 1 System for Venous, Arterial and Capillary Whole Blood Specimens in	16
B-302 Increased False-Positives vs Increased Interference Flags: Using the AU 5800 to Compare Two Ethyl Glucuronide Assays	16
B-186 Pericentric Inversion of Chromosome 9-inv(9)(p12q13): Findings Beyond Infertility Encountered on a Retrospective Study	16
A-119 Lipemia Interference	16
B-086 High Precision T Cell Testing Using the T-SPOT Technology: Improved Cell Yields From Lower Volumes of Blood When the T-SPOT Technology is Used With the T-Cell Select Reagent Kit for Cell Isolati	16
A-166 Performance verification of a polyclonal anti-PF4 immunoassay in evaluation of Heparin Induced Thrombocytopenia (HIT)	16
A-086 Clinical Performance of a Plasma ATN Panel for Assessment of Alzheimer’s Disease	16
B-230 Monitoring SARS-CoV-2 Subvariants for Evaluation of the Diagnostic Kit’s Annealing Site Using Nanopore Sequencing	16
B-089 Development of a Secondary Standard for Quantitation of IgG Antibodies to SARS-CoV-2 Proteins in a Multiplex Assay	16
B-214 Serial Changes of Donor-derived Cell-free DNA in Pancreas Transplant Recipients	16
A-302 Agreement Assessment Between Molecular and Rapid Tests in Respiratory Viruses Detection	16
B-149 Next-generation Sequencing Via Targeted Metagenomics for Broad Antimicrobial Resistance Surveillance	15
A-052 Clinical usefulness of ADAMS A1c HA-8190V automatic switching mode for the HbA1c measurement in Hb variants	15
A-038 Interlaboratory Comparison of Parathyroid Hormone Analytical Results Across Clinical Assays from 8 Manufacturers - Steps Towards Standardization	15
A-167 Hematologic setpoints are a deep physiologic phenotype which enable personalized blood count reference intervals	15
B-321 Development of Chemiluminescent Enzyme Immunoassay (CLEIA) for Detecting Methotrexate in Blood	15
B-206 The Determination of Vanillylmandelic Acid (VMA), Homovanillic Acid (HVA) and 5-Hydroxyindolacetic Acid (5-HIAA) by LC-Ms/MS Assay in Urine Samples for Diagnosis of Neuroendocrynes Tumors	15
A-114 Protective effect of leukocytes in preventing Cold Induced Hyperkalemia	15
B-141 Surprisingly Good Agreement of Siemens and Roche ALT Reference Change Values in Ottawa Hospital Outpatients Distilled from 5 years and 3 years of Siemens and Roche ALT, Respectively	15
A-021 Evaluation of a Novel N Terminal Pro B Type Natriuretic Peptide Assay as an aid in the Diagnosis of Acute Heart Failure in the Emergency Department	15
Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus	15
Transitioning Alzheimer Disease Blood Biomarkers into Primary Care: Are We There Yet?	14
Vaccinate Me	14
Placental Biomarker Testing for Evaluation of Suspected Preeclampsia	14
LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial	14
NEJM Knowledge+/AACC Learning Lab Contributors 2021	14
Determinants of Cardiac Myosin Binding Protein C in the General Population	14
Commentary on No Monoclonal Protein in a Patient with CRAB Features	14
Reference Interval Harmonization: Will Big Data Provide a Solution?	14
In Reply to Beyond the Screen Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects	13
Do You See What I See? Automated IFE Interpretation Using Machine Learning	13
Next-Level Natriuretic Peptide Measurement	13
Commentary on Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis	13
Commentary on An Unusual Presentation of Autoimmune Primary Adrenal Insufficiency	13
Extent of Equivalence of Results for Urine Albumin among 3 Candidate Mass Spectrometry Reference Measurement Procedures	13
More Than a Decade of Rapid Genomic Sequencing: Where Are We Now?	13
Liquid Biopsy: Blood-Based Analyses of ctDNA and CTCs	13
Patient with a New Small IgG Kappa Monoclonal Protein	13
A-191 Improvement of Outpatient Satisfaction Rate at Specimen Collection Area	12
Evaluation of Sperm DNA Integrity by Mean Number of Sperm DNA Breaks Rather Than Sperm DNA Fragmentation Index	12
B-278 Pilot Clinical Study of the CarePoint Assay	12
Detection of Clinically Relevant Monogenic Copy-Number Variants by a Comprehensive Genome-Wide Microarray with Exonic Coverage	12
A-219 A Multiplexed Targeted Assay for Gangliosides Using Liquid Chromatography-Tandem Mass Spectrometry	12
A-297 Usefulness of Non-Skin Samples in the PCR Diagnosis of Monkeypox	12
Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study	12
Personalized and Population-Based Reference Intervals for 48 Common Clinical Chemistry and Hematology Measurands: A Comparative Study	12
A-258 Hepatitis A infections among patients suspected of acute hepatitis attended in Brazilian health services	12
A-156 White Blood Cell Measurands, Flagging and Scatter Plot Patterns in Chronic Lymphocytic Leukemia	12
A-228 Performance Evaluation of the LabGenius C-CT/NG-BMX Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae	12
B-098 Clinical comparison of five assays for the detection of anti-dsdna antibodies and their correlation with complement consumption	12
Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin	12
B-208 Correlation Studies of Human Papillomavirus DNA on Roche Cobas vs Human Papillomavirus mRNA on Hologic Panther	12
A-353 Lay User testing of Rapid Multiplexed HIV/TP test	12
A-346 Evaluating 14-3-3η Detection in Finger Prick Blood Using Lateral Flow Technology: Advancing Clinical Laboratory Diagnostics	12
A-322 Implementation of Three Age- and Sex-Dependent Equations to Estimate Glomerular Filtration Rates (eGFR) at a Pediatric Institution	12

B-233 Chromatin Accessibility Uncovers KRAS-driven FOSL2 Promoting Pancreatic Ductal Adenocarcinoma Progression Via Upregulating CCL28	11
A-009 Analytical Characterization of a Novel NT-proBNP Assay on a Central Laboratory Platform	11
Challenges in Hb A1c Point-of-Care Testing: Only 5 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation	11
A-389 Implementation of a solicited laboratory workflow improves quality indicators for point of care blood gas testing by Respiratory Therapists	11
B-056 Performance Characteristics of a New, Fully Automated Planar Microarray Immunoassay for the Detection of IgG Auto-Antibodies Against Centromere Protein B (CENP-B)	11
A-073 Is there a relationship of FIB 4 with weight and insulin resistance in subjects without type 2 diabetes and with normal transaminases?	11
A-049 Inter-assay Variation of Insulin-like Growth Factor-1 Remains an Issue	11
B-220 Clinical Application of the “Clg-Fish” Technique for the Diagnosis of Multiple Myeloma	11
B-308 Analytical and clinical performance of a novel ovarian cancer screening test in asymptomatic women	11
A-054 Comparison of a Reformulated Vitamin D Immunoassay, Its Predecessor, and Two Contemporary Formulations	11
A Validated Highly Sensitive Microsatellite Instability Assay Accurately Identifies Individuals Harboring Biallelic Germline PMS2 Pathogenic Variants in Constitutional Mismatch Repair Deficienc	10
Clinical Decision-Making Suffers from Inequivalent Measurement Results and Inadequate Reference Intervals	10
A-233 Novel Microfluidic System for Antimicrobial Susceptibility Testing	10
B-054 Performance Evaluation of the VITROS HIV Combo Assay on the Ortho VITROS 3600 system	10
A Push for Real Normal: Mass Screening for COVID-19	10
Government Mandates Immediate Access to Cancer Test Results: Patient Empowerment or Secondary Harm?	10
Plasma microRNA Interindividual Variability in Healthy Individuals, Pregnant Women, and an Individual with a Stably Altered Neuroendocrine Phenotype	10
B-181 Multi-centre Analytical Performance Evaluation of the EXENTâ Solution for Identification and Quantitation of Monoclonal Immunoglobulins	10
Commentary on Positive Syphilis Serologies after Intravenous Immunoglobulin Treatment: A Diagnostic Confusion That Needs Emphasis	10
Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity	10
The Pivotal Role of Whole Genome and Transcriptome Sequencing in a Rare Case of Systemic Mastocytosis with Associated Myelodysplastic/Myeloproliferative Neoplasm with Neutrophilia	10
Polygenic Risk Scores: Genomes to Risk Prediction	10
Interpreting EQA—Understanding Why Commutability of Materials Matters	10
B-321 Enhancing Early Detection of Prostate Cancer Using PSA-Guided Screening in High-Risk Men Under 50	9
B-167 Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Treosulfan and Busulfan	9
A-072 Growth hormone stimulation tests: experience of a large cohort from a Brazilian diagnostic medical center	9
An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond	9
A Longitudinal Study of Plasma Glycated Albumin across Pregnancy and Associations with Maternal Characteristics and Cardiometabolic Biomarkers	9
Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies—Information Everybody Wants but Nobody Wants to Pay For	9
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review	9
Clinical Metagenomics—from Proof-of-Concept to Routine Use	9
Commentary on Severe Hypophosphatemia: The Hidden Truth	9
B-117 Rapid Classification of Cleanliness Grades of Vaginal Discharge through Computational Analysis of SERS Spectra via Variational Auto-Encoder Model And Long Short-Term Memory Networks	9
B-006 Use of Sysmex UN-3000 Research Parameters for Semiquantitative Analysis of Urine Microscopic Elements	9
B-099 Development and Improvement of Novel MASTM Infectious Controls for Serology Diagnostic Tests	9
The United States’ SARS-CoV-2 Testing Challenges Underscore the Need to Improve Surveillance Ahead of the Next Health Security Crisis	9
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination	9
Is Hemodialysis So Efficient in Removing Phosphate?	9
Pediatric Vaccine-Induced Antibody Thresholds: Rethinking Pre-Immunosuppression Serologic Testing and Revaccination Implications	9
Autoverified Chocolate-Colored Plasma Samples	9
B-075 Evaluation of patients with monoclonal gammopathy of undetermined significance using Optilite Freelite assays	9
The Next Generation of Population-Based DFNB16 Carrier Screening and Diagnosis: STRC Copy-Number Variant Analysis from Genome Sequencing Data	9
ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease	9
An Effective and Universal Long-Read Sequencing-Based Approach for SMN1 2 + 0 Carrier Screening through Family Trio Analysis	9
Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood	9
Cardiac Troponin I and T Ratio and Risk of Cardiovascular or Non-Cardiovascular Events in a General Population	9
A-327 Pre-analytical and Analytical Modifications to Improve the Quality of Pediatric Lead Tests	8
B-340 Evaluation of the Analytical Performance of Three Major Immunoglobulins Assays on the Atellica CI Analyzer	8
A-004 Analytical Assessment and Expanded Stability Studies of the Abbott Alinity i STAT High Sensitivity Troponin-I Assay	8
B-177 Quantitative Measurement of Vitamin B1 in Whole Blood using a Multiplex ESI-LC-MS/MS System	8
B-161 Liquid chromatography/mass spectrometry analysis of ethyl glucuronide and ethyl sulfate using a perfluorophenyl stationary phase	8
B-172 Correlation of Microbiome Sequencing Data and Quantified Short-Chain Fatty Acids by LC-MS/MS in IBD and Non-IBD Stool Samples	8
B-248 Enhanced Detection of of Hemoglobin Variants in Clinical Research using Dried Blood Spot and HRAM MS	8
A-088 Establish Laboratory Limit of Blank and Limit of Detection for LH Assay on the Ortho VITROS 3600 System	8
A-025 Principal Component Analysis as a Clustering Method for the Identification of Populations with Risk of Diabetes Development	8
B-165 The EXENT System reliably distinguishes daratumumab from endogenous monoclonal immunoglobulins in multiple myeloma patients	8
A-351 Versatile and Sensitive Microfluidic Immunoassay for Improved Point-of-Care Diagnostics	8
B-212 Laboratory Performance in Molecular Detection of Mycobacterium tuberculosis Through Analysis of External Quality Assessment Program Results: WHO-Recommended Tests Outperform Others	8
A-306 Standardization of Automated Methodology for Qualitative Molecular Detection of HIV-1 in Dried Blood Spots (DBS)	8
FDA Regulation of Laboratory Clinical Decision Support Software: Is It a Medical Device?	7
B-240 Development of AcroMetrixTM Human Microbiome Quality Control Materials	7
Short Timeframe Prediction of Kidney Failure among Patients with Advanced Chronic Kidney Disease	7
B-303 Comparison of Tacrolimus Concentrations Obtained By the Newly Approved Alinity i Tacrolimus Assay With a Reference Liquid-Chromatography Combined With Tandem Mass spectrometry Assay	7
B-069 Performance Evaluation of a Ma2 Autoantibodies ELISA	7
B-184 Development and Validation of a High-performance Liquid Chromatography-Mass Spectrometry Method for Analyzing Phenolic Acids Metabolites in Feces	7
The Importance of Discordance	7
B-253 Performance Characteristics and Validation of Next-Generation Sequencing for Human Leucocyte Antigen Typing	7
A-262 Analytical and Clinical Validation of a Multiplex RT-PCR based Mpox Assay	7
Next-Generation Methods for More Precise Measurement of Cancer Genetic Changes	7
A-362 Hemolysis Detection and Flagging of Potassium Results on GEM Premier 7000 with iQM3	7
Commentary on Diagnostic Odyssey in a Child with Red-Colored Urine and Proteinuria	7
B-203 Development and Validation of an LC/MS/MS Method to Quantify Creatinine in Dried Blood Spots	7
A Professional Skeptic	7
A-153 Study of the evaluation of fragment flag and percentage schistocyte count in MINDRAY® BC-6800 PLUS in a public pediatric hospital in Argentina	7
A-251 Comparison of Antimicrobial Susceptibility Profiles of Enterobacteriaceae spp. Isolates from Retail Meat Products Imported from USA and Brazil or Domestically Produced on Caribbean Island	7
B-336 Comparison of the LZI Fentanyl Enzyme Immunoassay With ARKII and SEFRIA Fentanyl Assays on Beckman AU Analyzer	7
A-379 Frequency of Reassignment of Blood Gas Sample Source at a Large Tertiary Care Hospital	6
B-029 Validation of an Automated Analyzer for Urine Microscopic Examination	6
A-179 Improving specimen labeling errors in the pediatric emergency department at a tertiary care hospital	6
A-156 Comparison of blast and variant lymphocyte flagging between the Alinity hq from Abbott and XN-1000 from Sysmex	6
A-288 Molecular Detection of Mycobacterium tuberculosis in Pulmonary and Extra-Pulmonary Samples. Data from a Brazilian Clinical Laboratory	6
B-013 Association Between Laboratory Parameters Analysis and Clinical Severity in Patients With Coronavirus Disease (Covid 19) at Hospital Universitario Fundación Santa Fe	6
Reducing the Noise in Plasma Metagenomics to Further Define Clinical Utility	6
B-101 Assessing the Performance of Cerebrospinal Fluid Kappa Immunoglobulin Free Light Chain as a Diagnostic Marker for Multiple Sclerosis Using Automated Chart Review	6
A-057 Cerebrospinal Fluid Prolactin in Patients with Neurological Disorders	6
A-233 Wastewater-based surveillance for SARS-CoV-2 Subvariants using the Nanopore Sequencing in South Korea	6
A-226 Validation of Calculated Glycerol Corrected Triglycerides	6
B-153 Improving Accuracy of IgG subclasses Quantitation in Serum Using Liquid Chromatography - Tandem Mass Spectrometry (LC-MS/MS) on SCIEX 7500	6
A-359 Performance of Measured TCO2 on the epoc Analyzer	6
B-108 Delta Check Performance Assessment by Using Real-WorldData at the Temple University Health System​	6
B-297 Tacrolimus Concentrations in Envarsus vs Prograf Patients: An Evaluation of the Clinical Impact of LC-MS/MS and Immunoassay Methods on Tacrolimus measurement	6
B-142 Development and Clinical Validation of Artificial Intelligence Assisted Flow Cytometry Diagnosis for Acuteleukemia	6
A-335 Evaluation of the Next Generation i-STAT® Point of Care Prothrombin Time Test	6
B-040 Performance Evaluation of Five Reproductive Endocrinology Assays on the Atellica CI 1900 Analyzer	6
Robotic Process Automation in Laboratory Medicine	5